Globus Medical Inc. (GMED)
NYSE: GMED
· Real-Time Price · USD
55.31
-1.44 (-2.54%)
At close: Sep 24, 2025, 3:59 PM
56.00
1.24%
After-hours: Sep 24, 2025, 07:11 PM EDT
-2.54% (1D)
| Bid | 55.11 |
| Market Cap | 7.47B |
| Revenue (ttm) | 2.63B |
| Net Income (ttm) | 356.65M |
| EPS (ttm) | 2.58 |
| PE Ratio (ttm) | 21.44 |
| Forward PE | 15.54 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 57.25 |
| Volume | 1,059,543 |
| Avg. Volume (20D) | 1,430,769 |
| Open | 56.77 |
| Previous Close | 56.75 |
| Day's Range | 55.30 - 56.98 |
| 52-Week Range | 51.79 - 94.93 |
| Beta | 1.17 |
| Ex-Dividend Date | n/a |
About GMED
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GMED
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GMED stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGlobus Medical Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.47%
Globus Medical shares are trading higher after the...
Unlock content with
Pro Subscription
1 month ago
+2.35%
Globus Medical shares are trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · fool.com
Globus Medical (GMED) Q2 Revenue Up 18%Globus Medical (GMED) Q2 Revenue Up 18%
